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Abstract
The neural cells and factors determining normal vascular growth
are not well defined even though vision-threatening neovessel
growth, a major cause of blindness in retinopathy of prematurity
(ROP) (and diabetic retinopathy), is driven by delayed normal
vascular growth. We here examined whether hyperglycemia and
low adiponectin (APN) levels delayed normal retinal vasculariza-
tion, driven primarily by dysregulated photoreceptor metabolism.
In premature infants, low APN levels correlated with hyper-
glycemia and delayed retinal vascular formation. Experimentally in
a neonatal mouse model of postnatal hyperglycemia modeling
early ROP, hyperglycemia caused photoreceptor dysfunction and
delayed neurovascular maturation associated with changes in the
APN pathway; recombinant mouse APN or APN receptor agonist
AdipoRon treatment normalized vascular growth. APN deficiency
decreased retinal mitochondrial metabolic enzyme levels particu-
larly in photoreceptors, suppressed retinal vascular development,
and decreased photoreceptor platelet-derived growth factor
(Pdgfb). APN pathway activation reversed these effects. Blockade
of mitochondrial respiration abolished AdipoRon-induced Pdgfb
increase in photoreceptors. Photoreceptor knockdown of Pdgfb
delayed retinal vascular formation. Stimulation of the APN path-
way might prevent hyperglycemia-associated retinal abnormalities
and suppress phase I ROP in premature infants.
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Introduction
About 15 million preterm infants are born yearly with an incom-
pletely vascularized retina (Hellstrom et al, 2013), which fails to
develop normally after birth as it would in utero. Failure of normal
neurovascular growth is the primary cause of later vision-threa-
tening pathologic angiogenesis driven by hypoxia and fuel insuffi-
ciency of the non-vascularized retina. It has been assumed that
supplemental oxygen is the major cause of delayed retinal vascular-
ization in preterm infants. However, fuel demand from retinal
neurons, particularly photoreceptors, is very high (Wong-Riley,
2010), and photoreceptor metabolic alterations can control patho-
logical angiogenesis (Joyal et al, 2016). We hypothesized that
photoreceptor fuel metabolism also controls normal vessel growth
(Fulton et al, 2009; Akula et al, 2010).
In very premature infants, hyperglycemia in the early postnatal
weeks strongly correlates with later retinal neurovascular develop-
ment (Garg et al, 2003; Ertl et al, 2006; Chavez-Valdez et al, 2011;
Kaempf et al, 2011; Mohamed et al, 2013; Ahmadpour-Kacho et al,
2014; Mohsen et al, 2014; Au et al, 2015). It is unknown whether or
how hyperglycemia suppresses retinal vessel growth. Postnatal
hyperglycemia occurs in ~80% of preterm infants born weighing
< 750 g and ~45% of preterm infants born < 1,000 g (Dungan et al,
2009), but the cause and results of hyperglycemia are not well
understood. Exogenous insulin does not adequately regulate hyper-
glycemia nor prevent hepatic gluconeogenesis in these infants
(Chacko et al, 2011). Insulin resistance and defective islet b-cell
processing of pro-insulin probably influences preterm hyper-
glycemia (Mitanchez-Mokhtari et al, 2004). We hypothesized that
the metabolic modulator APN is involved (Scherer et al, 1995;
Oberthuer et al, 2012). As low serum APN in preterm infants
predicts later pathological angiogenesis (Fu et al, 2015), we hypoth-
esized that APN modifies the suppressive effects of hyperglycemia
on neuronal metabolism to control normal vascularization. With the
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clinical investigation in premature infants and the experimental
exploration in a newly established mouse model of hyperglycemia
in early ROP, we found that hyperglycemia correlates with delayed
retinal vascular development and modulation of the APN pathway
protects against retinal vascular developmental delay.
Results
Hyperglycemia correlated with delayed retinal vascular
development and with low APN levels in premature infants
We correlated hyperglycemia with serum APN concentrations (di-
vided into tertiles) in a prospective longitudinal study of 50 preterm
infants. Mean plasma glucose levels were lower in higher APN
tertiles in postnatal weeks 1 and 2 (Fig 1A). APN levels increased in
all premature infants during the early postnatal period (Fig 1B)
although preterm infants with delayed retinal vascularization had
lower APN levels than those with normal retinal vascularization
(Fig 1B and C). This suggested that hyperglycemia correlated with
suppressed normal retinal vascularization and APN might counter-
act the impact of hyperglycemia and delayed neurovascular retinal
development.
Induction of hyperglycemia delayed retinal neurovascular
maturation in mice
To clarify the influence of hyperglycemia and APN on retinal neural
development, particularly photoreceptors, and on retinal vascular-
ization in the early postnatal period, we established a neonatal
mouse model of hyperglycemia-associated retinopathy (HAR)
(phase I ROP comprising poor vessel development) (Fig 2). In
human and mouse retina, blood vessels grow from the central to the
peripheral retina in three layers. In mouse, the superficial layer
forms at postnatal (P) days 1–10, the deep layer at P8-P12, and
the intermediate layer at P14-P20 (Fig 2A; Dorrell & Friedlander,
2006). In the model of hyperglycemic-associated retinopathy, we
injected streptozotocin (STZ, 50 mg1 kg1 day1) intraperi-
toneally into C57BL/6J (wild type; WT) mice from P1-P9 (Fig 2A).
Hyperglycemic versus normoglycemic retinas had suppressed deep
vascularization with fewer vascular meshes, reduced vessel
length, and reduced vascular area (Figs 2B and C, and EV1A).
The body weight of hyperglycemic and control mice was compara-
ble (Fig EV1B), suggesting that the delay in retinal vascularization
was not secondary to general growth retardation. Hyperglycemia
was induced at P8 (Fig EV1C). As expected, STZ-treated mice had
distorted pancreatic islet cells (Fig EV1D). Notably, the vascular
developmental delay was found only in the deep layer (Fig EV1E),
which is closest to photoreceptors, consistent with our hypothesis,
that the high metabolic demands of photoreceptors might direct
vessel growth. Insulin treatment rescued the deep layer vessel
growth (Fig EV1F), further confirming that hyperglycemia induced
retinal vascular abnormality. Elevated blood glucose and triglyc-
eride levels and reduced insulin levels were found at P10
(Fig 2D). No significant changes in triglyceride levels were
observed at P8 (Fig EV1C). Intravitreal STZ injections had no
direct effect on retinal vascularization (Fig EV2A), suggesting that
delayed vessel growth was secondary to hyperglycemia and/or
insulin deficiency.
The APN pathway modulated retinal vascular development in
hyperglycemic retinopathy
We then assessed whether APN modulated HAR. In hyperglycemic
mice, there was a 1.5-fold increase in serum APN levels, while reti-
nal Apn levels were low and comparable (Fig 3A). In retinal
A B C
Figure 1. Hyperglycemia positively correlated with low serum APN levels and low APN levels positively correlated with delayed retinal vascularization in
premature infants (gestational age at birth: 23–30 weeks, birth weight: 348–1,716 g).
A Mean weekly APN levels and 95% confidence interval for mean plasma glucose concentration in relation to APN level tertiles (T). At postnatal weeks 1 and 2, infants
in the Tlow APN had significantly higher mean plasma glucose concentrations than infants in the Thigh. APN Tlow 3.86 (range: 1.79–5.97) lg ml
1 (red), APN Tintermediate
8.63 (range: 6.43–11.54) lg ml1 (yellow), and APN THigh 17.50 (11.84–36.00) lg ml
1 (green). n = 50, **P < 0.01; ***P < 0.001. t-test.
B Mean weekly APN levels and 95% confidence interval in infants with normal (blue) versus delayed (red) vascularization. n = 44, ***P < 0.001. t-test.
C Schematics of retinal vascularization in premature versus term infants. Preterm (red) versus term (blue) infants had delayed retinal vascularization. Circles in red
represent zones of retina in preterm infants.
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neurons and vessels isolated with laser microdissection, APN recep-
tor 1 mRNA (AdipoR1) was highly expressed in photoreceptors
(ONL) and AdipoR1 was increased in HAR (Fig 3B).
To evaluate the influence of APN on ocular vessels in normo-
glycemic and hyperglycemic mice, we first evaluated hyaloid vessel
regression (Fig 3C). In both mice and human eyes, the hyaloid
vessels are the first to form in utero and regress as the retinal vessels
develop (Ito & Yoshioka, 1999; Stahl et al, 2010). In humans,
hyaloid vessels normally regress before term birth but are present at
birth in preterm infant eyes (Jones, 1963); chronically persistent
hyaloid remnants are associated with delayed retinal vascular devel-
opment and visual dysfunction (Sharma & Biswas, 2012). We found
that hyperglycemia and APN deficiency led to delayed regression of
the hyaloid vessels at P8 (Fig 3C). Hyaloid persistence was greater
in Apn/ eyes (35 of 37; 94.5%) versus WT eyes (31 of 48; 64.5%)
at P30 (Fig 3D), suggesting that hyperglycemia and low APN might
lead to hyaloid persistence in premature infants.
Given that APN deficiency delayed hyaloid regression, we then
examined the effect of APN deficiency on normal retinal vascular-
ization. APN deficiency attenuated superficial but not deep retinal
vascularization in normal condition at P10 (Fig EV2B). In hyper-
glycemic Apn/ versus hyperglycemic WT mice (mean glucose
Apn/: 206  8 mg dl1; WT: 197  6 mg dl1), deep vascular
formation was suppressed (Figs 3E and EV2C). To evaluate whether
activation of the APN pathway could normalize retinal vasculariza-
tion, we treated WT hyperglycemic mice with recombinant mouse
APN or APN receptor 1 and 2 dual agonist, AdipoRon (Okada-Iwabu
et al, 2013) (administrated from P7 to P9 when the deep layer starts
to form). Both reversed the vascular developmental suppression
(Figs 3F and G, and EV2D and E). We speculated that APN
A
C D
B
Figure 2. A novel mousemodel of hyperglycemia-associated retinopathy (HAR)was established and comparedwith normoglycemic controls in P10 neonates..
A The mouse neonates received intraperitoneal injection of STZ and schematic graph shows mouse retinal vessel development after birth (left). GCL, ganglion cell layer;
INL, inner nuclear layer; ONL, outer nuclear layer.
B Representative images of the deep vascular network in isolectin-stained (red, top) retinal whole mounts of HAR and controls. Scale bar, 50 lm (top) and 1 mm
(bottom). The total retinal area is outlined in yellow and deep vascular coverage is highlighted in red (bottom, grayscale).
C Quantification of deep vascular network of HAR and controls. n = 17–27 retinas/group. Data presented as mean  SEM, unpaired t-test.
D Blood glucose (n = 19–27 retinas/group), serum insulin (ELISA) (n = 4–7 pooled samples/group) and triglyceride (TG) concentrations (n = 7/group) of HAR and
controls. Data presented as mean  SEM, unpaired t-test.
Data information: See also Fig EV1.
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activation of AdipoR1 in photoreceptors might control vasculariza-
tion as AdipoR1 was the most highly expressed APN receptor in
mouse retina and was localized mainly in photoreceptors (Fig 3B).
The APN pathway regulated retinal metabolism and
photoreceptor neurovascular growth factor production
Given that APN is a key metabolic modulator, we examined APN’s
effect on retinal metabolic enzyme concentrations in hyperglycemic-
associated retinopathy with quantitative proteomics. APN deficiency
decreased the level of enzymes involved in glucose metabolism, the
Krebs cycle and the electron transport chain (Fig 4A), suggesting a
reduction in metabolism and energy production with APN defi-
ciency. In retinal punches, decreased the oxygen consumption rate
(OCR, an indicator of mitochondrial respiration) and extracellular
acidification rate (ECAR, an indicator of glycolysis) was seen in
hyperglycemic retina (Fig EV3A); msAPN increased OCR (Fig 4B)
and ECAR (Fig EV3F) in WT HAR retinas. Metabolic enzyme Hk1
and Cs mRNA levels were reduced in photoreceptors (ONL, Fig 4C)
but not in vessels (Fig EV3B), suggesting that the leading contribu-
tion to metabolic alterations in hyperglycemic Apn/ retinas was
photoreceptors.
We confirmed our findings in photoreceptors in vitro. In immor-
talized cone photoreceptor cells (661W), AdipoRon induced phos-
phorylation of AMP-activated protein kinase (AMPK, a key mediator
of APN in modulating mitochondrial function in diabetes (Iwabu
et al, 2010; Fig 4D) and increased Hk1 and Cs levels (Fig 4E).
AdipoRon reversed hyperglycemia-induced disruption of mitochon-
drial morphology and increased mitochondrial fusion protein
production (Fig EV3C–E), suggesting that AdipoRon prevented mito-
chondrial fission, an early event in cell death (Knott et al, 2008).
AdipoRon also increased OCR and ECAR (Figs 4F and EV3G), con-
firming that the APN pathway promotes photoreceptor oxygen and
glucose use. Inhibition of AMPK with Compound C (McCullough
et al, 2005; Liu et al, 2014) attenuated the protective effects of
msAPN on retinal vascular development in HAR (Fig EV3H), further
suggesting AMPK is an essential mediator in APN pathway. Finally,
AdipoRon increased platelet-derived growth factor B (Pdgfb), which
promotes retinal vascular growth in mice (Lindblom et al, 2003).
Inhibition of adenosine triphosphate synthase with oligomycin abol-
ished the AdipoRon induction of Pdgfb in 661W cells (Fig 4G).
msAPN administration increased retinal expression of Pdgfb
(Fig 4H). Pdgfb expression was decreased in photoreceptors of
Apn/ versus WT mice (Fig 4I). Photoreceptor-specific knockdown
of Pdgfb inhibited retinal vascular network formation in WT mice
(Fig 4J and K). APN deficiency decreased Vegfa expression in the
ONL while photoreceptor-specific knockdown of Vegfa did not
change retinal vascular formation in WT mice (Fig EV4A and B).
APN restored hyperglycemia-suppressed retinal function
We obtained electroretinographic (ERG) recordings in hyper-
glycemic mice. Mathematical modeling of the photoreceptor
response, captured in the leading edge of the electroretinographic a-
wave (Hood & Birch, 1994), detected change in photoreceptor
amplitude (RmP3) and in post-receptor response sensitivity (r) and
amplitude (Vm). This resulted in a decrease in retinal sensitivity
(Sm) (Akula et al, 2008; Fig 5A). The changes in post-receptor sensi-
tivity correlated with the sum of deficits in photoreceptor sensitivity
and saturated amplitude (Fig 5B), seen in premature infants
(Hansen et al, 2016). Decreased thickness of the photoreceptor layer
was observed in hyperglycemic retinas (Fig 5C). Long-term adminis-
tration of mouse recombinant APN (msAPN) rescued post-receptor
responses (Vm) in rod and cone ERG (Fig 5D and E), reflecting
better photoreceptor function.
In summary, APN pathway activation improved photoreceptor
function during hyperglycemic stress, by increasing mitochondrial
activity and inducing neurovascular growth factor production
(PDGFB, not VEGFA, Fig 6) in photoreceptors, which improved
normal retinal vascularization.
Discussion
We found that in premature infants, hyperglycemia was associated
with delayed retinal vascularization, and correlated with low circu-
lating APN levels. In our mouse model of HAR, activation of the
APN pathway reversed hyperglycemia-associated suppression of
photoreceptor metabolism and increased the consumption of oxygen
and glucose, stimulated neurovascular growth factor (PDGF)
production, and normalized vascularization necessary for oxygen
and nutrient supply. APN deficiency worsened hyperglycemia-
associated suppression of retinal neurovascular maturation (Fig 5).
In premature infants, early hyperglycemia coinciding with phase
I of ROP contributes to the later progression of the neovascular
phase of ROP (Garg et al, 2003; Ertl et al, 2006; Chavez-Valdez
et al, 2011; Kaempf et al, 2011; Mohamed et al, 2013; Ahmadpour-
Kacho et al, 2014; Mohsen et al, 2014; Au et al, 2015). We
◀ Figure 3. APN pathway activation protected against hyperglycemia-associated retinopathy (HAR) delay in P10 neonatal mice.A Left: serum APN levels (ELISA) (n = 8–9 retinas/group); right: retinal apn (qRT–PCR) (n = 6 retinas/group) of HAR and controls.
B Left: retinal cross-sectional layers for laser capture microdissection (LCM: DAPI for nuclei, blue; isolectin for vessels, red); center: mRNA levels of AdipoR1 and
AdipoR2 in retinal neuronal layers and vessels. n = 3 pooled retinas/group. Right: AdipoR1 mRNA in HAR and control retinas. n = 5 retinas/group.
C Control and HAR eyes in WT and Apn/ mice. Left: representative images of DAPI-stained hyaloid vessels (blue). Right: quantification of preserved hyaloid vessels
branching from the hyaloid artery (white arrow). Scale bar, 1 mm. n = 8–30 retinas/group.
D Left: Fundus photograph focused to show persistent hyaloid vessels (white arrows) (green, fluorescein AK-FLUOR) in WT and Apn/ mice at P30 (n = 37–48
retinas/group); right: pie graph of percentage of eyes examined with persisting hyaloid.
E Left: In WT and Apn/ representative images of deep retinal vasculature (lectin, red) in whole-mounted retinas; right: quantification of deep vessels (n = 14–22
retinas/group).
F, G Left: Representative images of deep retinal vasculature (lectin, red) in whole-mounted retinas of WT hyperglycemic (HAR) mice with recombinant mouse APN
treatment (F) (n = 6–10 retinas/group) or with AdipoRon treatment (G). Right: quantification of deep retinal vasculature (n = 7–14 retinas/group).
Data information: Scale bars, 50 lm (B, E–G) or 1 mm (C). Data presented as mean  SEM; unpaired t-test (A, B, E–G) or ANOVA (C). See also Fig EV2.
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previously reported that low APN levels positively correlate with
retinal neovascularization in premature infants and APN mediates
the use of essential long-chain polyunsaturated fatty acids omega-3
in the retina to prevent pathological angiogenesis in mice (Fu et al,
2015). In adult patients, elevated serum APN levels in type 1
diabetes positively correlate with insulin sensitivity (Pereira et al,
2012) and plasma total antioxidant status (Prior et al, 2011). Serum
APN deficiency may contribute to insulin resistance in diabetes
(Iwabu et al, 2010) and an APN receptor 1 and 2 agonist reduces
plasma glucose in diabetic mice (Okada-Iwabu et al, 2013), suggest-
ing that APN may protect against hyperglycemia-associated meta-
bolic complications including retinal alterations. This suggestion is
supported by our results, which demonstrate that with low levels or
deficiency of APN, there is worse retinal vasculature development
in HAR.
Some reports suggest that vascular metabolism controls endothe-
lial cell growth (De Bock et al, 2013; Schoors et al, 2015). However,
we found that photoreceptor metabolism also controls blood vessel
growth. Retina (in particular photoreceptors) is the most metaboli-
cally demanding tissue in the body (Wong-Riley, 2010) and photore-
ceptors have the highest number of mitochondria of any cell (Hoang
et al, 2002). Early photoreceptor dysfunction predicts subsequent
pathological angiogenesis in neonatal rats (Akula et al, 2007, 2010).
Photoreceptor oxidative stress and inflammation disturbs the stabil-
ity of blood vessels in early diabetic retinopathy (Du et al, 2013;
Tonade et al, 2016). Other lines of evidence also show that AdipoR1
deficiency in mice is associated with decreased energy metabolism
(Bjursell et al, 2007) and loss of AdipoR1 leads to mouse photore-
ceptor degeneration (Rice et al, 2015). A gene mutation in ADIPOR1
causes human retinitis pigmentosa (with photoreceptor loss result-
ing in blindness) (Xu et al, 2016). These reports suggest that the
APN pathway may play an important role in maintaining photore-
ceptor metabolic homeostasis. Here, we found that there was
decreased metabolism in hyperglycemic retinas which improved
with activation of the APN pathway. Pharmaceutical administration
of APN protected against hyperglycemia-dampened rod and cone
function, which was reflected in post-receptor ERG responses.
Photoreceptors control developmental vascularization in the
retina and the APN pathway positively regulates photoreceptor
metabolism.
The hyperglycemia status was not further changed with APN
deficiency, suggesting that the impact of APN on retinal vascular
growth was not through the adjustment of circulating glucose levels.
Instead, APN directly regulated local retinal metabolism particularly
photoreceptors. APN deficiency decreased key metabolic enzymes
in hyperglycemic retinas, suggesting that stimulation of the APN
pathway in hyperglycemic mice promoted retinal cell mitochondrial
activity and glycolysis, which could compensate for the decreased
retinal metabolism due to the lack of insulin. Further activation of
the APN pathway with administration of recombinant APN or with
administration of the APN receptor agonist AdipoRon improved reti-
nal vascular formation through increased retinal and photoreceptor
metabolic activity.
In both normoglycemic and hyperglycemic retinas, APN defi-
ciency induced hyaloid vessel persistence, indicating that APN
modulation of hyaloid vessel regression occurred independent of
glycemic status. Retinal blood vessels normally branch from the
superficial layer to form the deep vasculature as the hyaloid vessels
regress, suggesting that persistent hyaloid vessels which supply
oxygen and nutrients to the inner retinal cells may contribute to the
reduced blood vessel network in the superficial retinal layer. Under
hyperglycemic conditions, APN deficiency worsened the photore-
ceptor metabolic dysfunction and further decreased the deep vascu-
lar formation. These observations suggest that APN may work
through different mechanisms to modulate hyaloid vessel regres-
sion, superficial and deep retinal vascular formation. There is a
sharp decrease in the hyaloid vessel counts from P5 to P8 in mice
(Rao et al, 2013). In HAR, hyperglycemia was induced from P6 to
P8. The rise in blood glucose levels may interrupt hyaloid vessel
regression during this sensitive period, which leads to persistent
hyaloid vessels. However, as the superficial retinal vessels cover
more than 50% of the retinas at P5 and almost reach the most
peripheral region at P8, the impact of hyperglycemia on superficial
vasculature may be mild. In Apn/ mice, there is an early influ-
ence of APN loss on hyaloid and retinal vessels. Further investiga-
tion of the influence of APN pathway on the systems controlling
◀ Figure 4. APN pathway activation modulated photoreceptor mitochondrial function in hyperglycemic mice.A Quantitative proteomic analysis of key glucose metabolic enzymes and mitochondrial metabolic enzymes in hyperglycemic (HAR) WT and Apn/ mice at P10. n = 6
mice/group. Blue: maximum of levels; orange: minimum of levels.
B Seahorse XFe96 Flux Analyzer oxygen consumption rate (OCR) of WT HAR P10 retinas treated with msAPN or vehicle (PBS). Basal: initial OCR without treatment;
max, maximal OCR: after addition of FCCP (carbonyl cyanide-4-trifluoromethoxy phenylhydrazone). Treatment with rotenone and antimycin A (RAA) reveals
non-mitochondrial respiration. ANOVA, *P < 0.05. n = 7–8 per group.
C mRNA expression of metabolic enzyme (Hk1, Cs) in retinal neuronal layers (ONL, INL, GCL) of Apn/ versus WT HAR P10 retinas (LCM and qRT–PCR). n = 3 pooled
retinas/group. ANOVA. n.s., not significant.
D Western blot for p-AMPK/AMPK in 661W cells treated with AdipoRon or vehicle. n = 4 per group. Unpaired t-test.
E qRT–PCR of key metabolic enzymes (Hk1, Cs) in AdipoRon- versus vehicle-treated 661W cells. n = 9 per group. Unpaired t-test. n.s., not significant.
F OCR of 661W cells treated with AdipoRon or vehicle. Leak indicates OCR independent of ATP production with proton leak induced with oligomycin (oligo) treatment.
n = 10 per group. ANOVA. *P < 0.05, **P < 0.01.
G qRT–PCR of Pdgfb in AdipoRon- or vehicle-treated 661W cells with and without oligomycin. n = 12 replicates/group. ANOVA.
H qRT–PCR of Pdgfb in msAPN- or vehicle-treated WT HAR retinas. n = 12 replicates/group. Unpaired t-test.
I Pdgfb expression in photoreceptors (ONL from LCM) from Apn/ versus WT HAR P10 mice (LCM and qRT–PCR). n = 4–5 replicates from three pooled retinas/group.
Unpaired t-test.
J qRT–PCR of Pdgfb in hRK-shPdgfb-transfected 661W cells. n = 9 per group. Unpaired t-test.
K Representative images of deep retinal vascular network and quantification in AAV2-hRK-Pdgfb-GFP versus AAV2-hRK-GFP (control) virus subretinally injected in WT
mice. Retinas were examined at P10. Scale bar, 50 lm. n = 8–12 retinas/group. Unpaired t-test.
Data information: Data presented as mean  SEM. See also Figs EV3 and EV4.
EMBO Molecular Medicine Vol 10 | No 1 | 2018 ª 2017 The Authors
EMBO Molecular Medicine Photoreceptor controls vessel growth Zhongjie Fu et al
82
hyaloid vessel regression and superficial retinal vascular formation
[e.g., retinal ganglion cells (Rao et al, 2013)] is needed to better
understand mechanisms. APN receptors were expressed in retinal
ganglion cells, although the expression was much less than in
photoreceptors. In summary, APN, possibly through targeting dif-
ferent retinal neurons, controls retinal vascular formation. Further
A
D
B
C
E
Figure 5. Recombinant APN treatment restored retinal function in hyperglycemia-associated retinopathy.
A Electroretinogram (ERG) assessment of retinal function in control and HAR mice showing photoreceptor response amplitude (RmP3), sensitivity (S), and post-
receptor response amplitudes (Vm), sensitivity (r), and retinal sensitivity (Sm). ERG parameters are presented as the log change from control mice. Representative
ERG waveforms (left). n = 10–12 per group. *P < 0.05, ***P < 0.001. ANOVA.
B Correlation of post-receptor sensitivity deficits (Logr) with the sum of deficits in photoreceptor sensitivity (LogSrod) and saturated amplitude (LogRrod). n = 10–12
per group. Pearson R test.
C Measurement of outer nuclear layer thickness in WT control and HAR retinas at P30. Representative images of H&E-stained retinal cross sections (left). Scale bar,
50 lm. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; ONL, outer nuclear layer. n = 6 per group. Unpaired t-test.
D, E Hyperglycemia was induced with 25 mg kg1 STZ (i.p., daily from P2 to P12) in WT mice. The mouse pups received msAPN (0.6 lg g1) or vehicle treatment daily
from P7 to P39. Littermate controls were used. At P40, rod (D) and cone (E) ERG were conducted. Cone ERG was reflected by post-receptor responses (Vm). n = 7 to
12 per group. **P < 0.001. ANOVA (D) or t-test (E).
Data information: Data presented as mean  SEM (A, C–E).
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exploration may greatly benefit patients with persistent hyaloid
remnants (Mullner-Eidenbock et al, 2004; Saint-Geniez & D’Amore,
2004; Shastry, 2009; Sharma & Biswas, 2012).
There are some limitations to our study. First, the neonatal
mouse model of STZ-induced HAR may not accurately mimic the
hyperglycemic status in premature infants with insulin deficiency
and insulin resistance (Mitanchez-Mokhtari et al, 2004). Second,
the mouse retina does not have a macula, rich in cone photorecep-
tors as seen in primates. Third, further study is needed to define
how photoreceptor metabolism influences vascular growth factor
production and to determine what factors are modulated by APN to
facilitate deep vascular growth. Although we demonstrate that
PDGFB not VEGFA are involved in the process, other factors may
also control blood vessel growth.
In summary, our data highlight the importance of hyperglycemia
and its influence on photoreceptor metabolism that mediates early
retinal neurovascular developmental delay. Targeting photoreceptor
metabolism may help prevent hyperglycemia-associated retinal
diseases like retinopathy of prematurity (ROP) and perhaps diabetic
retinopathy. APN is a potential therapeutic target in retinal meta-
bolic diseases.
Materials and Methods
Study design
This translational study aimed to explore the impact of hyper-
glycemia on retinal vascular development in premature infants and
the role of APN on neural retinal metabolism. In premature infants,
we correlated blood APN levels with blood glucose levels and retinal
vascularization. We then established a neonatal mouse model of
HAR to investigate APN control of neurovascular growth. In this
model, we evaluated retinal vascular development with APN defi-
ciency, or pharmacological supplementation of recombinant APN or
activation of APN receptors; the signaling pathways were also
evaluated.
Quantitative analyses of plasma glucose
Blood sampling for plasma glucose was performed from an umbili-
cal arterial catheter or a peripheral arterial line, and plasma glucose
was analyzed immediately after sampling by a blood gas analyzer
(ABL 735; Radiometer, Copenhagen, Denmark). In total, 2,128 arte-
rial samples were obtained and analyzed for plasma glucose during
postnatal days (PND) 1–21.
Blood sampling and quantitative APN analyses
Blood samples were obtained from umbilical cord blood at birth and
from neonatal blood prior to enteral feeding at 72 h of age, at 7 days
postnatally, weekly until at least a gestational age 35 weeks and
again at a term age (postmenstrual age 40 weeks). Sampling was
initially performed from an umbilical or peripheral arterial catheter
and later by venous puncture. After centrifugation, serum samples
were stored at 80°C until assayed.
All serum samples were diluted 1:306 and APN levels assayed
using a human adiponectin ELISA kit (E091M, Mediagnost, Reutlin-
gen, Germany). The intra-assay coefficients of variation were 3.8%
at 3.9 lg ml1 and 4.7% at 13.1 lg ml1; the inter-assay coefficient
of variation was 16.3% at 9.9 lg ml1. For values > 80 lg ml1,
samples were further diluted using assay diluent and the assay
repeated so that the results fell within the range. Samples were
corrected for respective dilution.
Examination of retinal vascular growth in premature infants
Examination of the retinal vascular growth started at 5–6 weeks of
age but not before 31 weeks PMA. Retinal examinations through
dilated pupils were performed biweekly to twice a week depending
Figure 6. Schematic of proposed APN pathway in photoreceptor metabolism and deep retinal vascular development in STZ-induced hyperglycemic
retinopathy.
The APN pathway phosphorylates AMPK to increase mitochondrial activity, which in turn increases the production of neurovascular growth factor PDGFB. Photoreceptor-
derived PDGFB (not VEGFA) promotes the deep retinal vascular network formation in hyperglycemic retinopathy.
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on the extension of delayed retinal vascular growth, until the retina
was fully vascularized.
Neonatal mouse model of hyperglycemia-associated retinopathy
The streptozotocin (STZ)-induced hyperglycemia in neonatal
C57BL/6J mice was adapted from previous studies (Cox et al, 2010;
Kermorvant-Duchemin et al, 2013). For each experiment, aliquots
of STZ were pre-weighed and kept in the dark at 20°C. STZ was
dissolved in phosphate-buffered saline (PBS) immediately before
injection to a final concentration of 50 mg1 ml1. 50 mg1 kg1
(1 ll g1) was administrated intraperitoneally daily from postnatal
days (P)1 to P9 using a 30-G needle (Hamilton syringe). Control
animals received an equal volume of PBS. The pups were returned
to their dams after the injection. The total volume injected depended
on the individual animal’s weight. Mice were sacrificed using a
lethal intraperitoneal injection of ketamine/xylazine, and eyes were
enucleated at P10. Body weight was recorded, and blood glucose
levels were determined using (glucose strip). Five mouse pups were
injected intravitreally with 0.5 ll STZ (2 mg ml1) at P1 to assess
the chemical toxicity of STZ on the developing retina. 0.5 ll PBS
was injected at the contralateral eye of the same pup as control.
Recombinant mouse APN (a combination of high-molecular-weight,
hexamer and trimer APN, i.p. 0.6 lg g1 in PBS, ALX-522-059-C050,
Enzo) or AdipoRon (oral gavage 50 mg kg1 in corn oil, Cayman)
was administrated from P7 to P9. Both male and female mice were
used. Littermates were administrated vehicle as control. Retinal
vasculature was examined at P10.
Quantification of retinal vasculature
APN knockout (Apn/) mice (JAX, #008195) were used. Apn/
mice have been backcrossed to C57BL/6J for 11 generations. P10
Apn/ and C57BL/6J (used as controls recommended by the
vendor) retinas were dissected, permeabilized with 1% Triton X-
100–PBS, and stained overnight at room temperature with fluores-
cent Griffonia Bandeiraea Simplicifolia Isolectin B4 (Alexa Fluor
594, I21413, Molecular Probes, 10 lg ml1) in 1 mM CaCl2 in PBS.
For quantification of retinal network formation, 4–5 images between
the optic nerve head and the leading edge of vessels in the superfi-
cial or deep vascular layers were taken at 200× magnification on a
Zeiss AxioObserver.Z1 microscope. The images were analyzed using
“Angiogensis analyzer” plugin in ImageJ. Background spurious
staining was cleaned manually and the image was converted to 8-bit
before analysis. Parameters included were the number of meshes
and total vessel length. For the quantification of deep retinal vascu-
lar coverage, the image of each quadrant was taken at 200× magnifi-
cation and merged to form one image with AxioVision 4.6.3.0
software. The images were saved in grayscale. The optic nerve head
was used as the reference point for the four quadrants. The vascular
area and total retinal area were quantified for each quadrant and
summed for the entire retina. The percentage of deep vascular
coverage over the total retinal area was calculated.
Electroretinography
Visual function was assessed with electroretinography (ERG) for
P30 mice as previously described (Sapieha et al, 2012). Mice were
dark-adapted overnight and anesthetized (ketamine/xylazine), and
pupils were dilated (Cyclomydril; Alcon, Fort Worth, TX, USA).
The stimuli were “green” light-emitting diode flashes of doubling
intensity from ~0.0064 to ~2.05 cd s m2 and then “white” xenon-
arc flashes from ~8.2 to ~1050 cd s m2. The stimuli were deliv-
ered using a Colordome Ganzfeld stimulator (Diagnosys LLC,
Lowell, MA). The a-waves representing saturating photoresponses
were estimated by fitting the free parameters in a model of the
biochemical processes involved in the activation of phototransduc-
tion to the electroretinographic a-waves (Lamb & Pugh, 1992;
Pugh & Lamb, 1993; Hood & Birch, 1994). The saturating
responses of b-waves were derived from the Naka–Rushton equa-
tion (Fulton & Rushton, 1978). The oscillatory potentials (OPs)
characterize the inner retina cell activity, which is distinct from
those generate a-waves and b-waves (Sapieha et al, 2012). All
electroretinographic data were presented as the log change from
normal (DLogNormal). To investigate the long-term impact of APN
on retinal function, 25 mg kg1 STZ was intraperitoneally injected
from P2 to P12, and msAPN or vehicle was given from P7 to P39.
ERG was conducted at P40.
Quantification of serum total APN, triglycerides, and
insulin levels
Serum APN levels were assayed using a human APN ELISA kit
(E091M, Mediagnost). Serum triglycerides levels were measured
using the Wako L-Type TG M test. Serum insulin was assayed using
mouse ultrasensitive insulin ELISA kit (80-INSMSU-E01, Alpco).
Laser capture microdissection
P10 eyes were enucleated and embedded in OCT compound. The
eyes were sectioned at 12 lm in a cryostat, mounted on RNase-free
polyethylene naphthalate glass slides (11505189, Leica), and imme-
diately stored at 80°C. Slides containing frozen sections were fixed
in 70% ethanol for 15 s, followed by 30 s in 80% ethanol and 30 s
in absolute ethanol, and then washed with DEPC-treated water for
15 s. Sections were stained with fluoresceinated Isolectin B4 (Alexa
Fluor 594—I21413, Molecular Probes, 1:50 dilution in 1 mM CaCl2
in PBS) and treated with RNase inhibitor (03 335 399 001, Roche) at
room temperature for 3 min. Laser dissection of retinal blood
vessels and retinal neuronal layers was performed immediately
thereafter with the Leica LMD 6000 system (Leica Microsystems),
and samples were collected directly into lysis buffer from the
RNeasy Micro kit (Qiagen, Chatsworth, CA, USA).
Examination of hyaloid vessel persistence
P8 eyes were enucleated and fixed in 4% paraformaldehyde for 1 h
at room temperature. The eyes were then intravitreously injected
with 1.5% agarose in PBS (pre-warmed at 37°C). After 20 min on
ice, the cornea was removed, followed by the iris, sclera, choroid,
and RPE. PBS was injected between the retina and the vitreous to
separate the two structures. The retina was then gently peeled off
from the vitreous body. The lens was then removed and the hyaloid
vessels were visualized with 40,6-diamidino-2-phenylindole (DAPI,
Vector, Burlingame, CA, USA). The images were taken at 50×
magnification on a Zeiss AxioObserver.Z1 microscope. The total
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number of persistent hyaloid vessels branching from the hyaloid
artery was manually counted.
Hyaloid persistence at P30 was examined with fluorescein
angiography. Mice were anaesthetized with ketamine/xylazine, the
pupil was dilated with Cyclomydril (Alcon), and the cornea was
anesthetized with proparacaine; 10 mg ml1 fluorescein AK-
FLUOR (NDC 17478-101-12, Akorn) was intraperitoneally injected
at 10 ll g1 body weight. Images were taken with the Micro IV reti-
nal imaging system.
Quantitative proteomics of retinal metabolic enzymes
Sample preparation
Both retinas from each mouse were pooled and homogenized in
200 ll Holt’s lysis buffer. For each homogenate, the protein
concentrations were measured with by the PierceTM BCA protein
assay, and the volume of homogenate containing 75 lg total
protein was taken for analysis. Sodium dodecyl sulfate (SDS) was
added to a final concentration of 1%. Bovine serum albumin,
8 pmol, was added as a non-endogenous internal standard. The
samples were heated at 70°C for 15 min to equilibrate the standard
before adding 1 ml acetone and incubating overnight at 20°C to
precipitate the proteins. The precipitated proteins were pelleted by
centrifugation at 10,000 × g for 10 min, and the acetone was
poured off and any residual acetone removed in a SpeedVac. The
dried protein pellet was reconstituted in 75 ll Laemmli sample
buffer; 20 ll aliquots, containing 20 lg total protein, were run
1.5 cm into a 12.5% SDS–PAGE gel (Bio-Rad). These short-run
gels were fixed, washed, and stained with Pierce GelCode Blue.
Each 1.5-cm lane was cut from the gel as a single sample, divided
into smaller pieces, and washed in ethanol/water/acetic acid (45/
45/10) to remove the stain.
In-gel digestion
The proteins contained in the samples were reduced with DTT, alky-
lated with iodoacetamide, and digested with 1 lg trypsin for over-
night at room temperature. The peptides were extracted in
methanol/water/formic acid (45/45/10) and the extract evaporated
to dryness in a SpeedVac. The dried peptide mixture was reconsti-
tuted in 150 ll 1% acetic acid for analysis.
LC-tandem MS analysis using selected reaction monitoring
(SRM) (Kinter & Kinter, 2013). The mass spectrometry system
was a Thermo Scientific TSQ Vantage with an Eksigent splitless
nanoflow HPLC system. The samples (7 ll aliquots) were
injected onto a 10 cm × 75 lm i.d. capillary column packed with
Phenomenex Jupiter C18 reversed-phase beads. The column was
eluted at 150 nl min1 with a 60-min linear gradient of acetoni-
trile in 0.1% formic acid. The SRM assays were developed to
monitor two peptides per protein. Each peptide was monitored
in a 6-min window centered on the known elution time of the
peptide (Kinter & Kinter, 2013). The data were processed using
the program Skyline to determine the respective chromatographic
peak areas (MacLean et al, 2010). The response for each protein
was taken as the geometric mean of the two peptides monitored.
Changes in the relative abundance of the proteins were deter-
mined by normalization to the BSA internal standard. The data
was presented as heat maps and the raw data are shown in
Table EV1.
Photoreceptor (661W) cell culture
Cone photoreceptor 661W was originally cloned from retinal tumors
of a transgenic mouse line that expresses the simian virus (SV) 40 T
antigen under control of the human interphotoreceptor retinol-
binding protein (IRBP) promoter and characterized by immunohis-
tochemistry and immunoblot (Tan et al, 2004). Cells were cultured
at 37°C, 5% CO2 in a humidified atmosphere in Dulbecco’s modified
Eagle’s medium (DMEM, #1196502, Gibco) supplemented with 10%
fetal bovine serum (#S12450, Atlanta Biologicals) and 1% peni-
cillin/streptomycin. No mycoplasma contamination of the cells was
detected using ATCC universal mycoplasma detection kit (30–
1,012 K). An equal number of cells per well was plated on the 6-
well dish and cultured to 80 to 90% confluence. The cells were
treated with 50 lM AdipoRon or DMSO as vehicle control for 24 h
and collected for protein and RNA.
Oxygen consumption rate and extracellular acidification rate
Oxygen consumption rate (OCR) and extracellular acidification rate
(ECAR) were measured using a Seahorse XFe96 Flux Analyzer (Joyal
et al, 2016). For retinal OCR and ECAR ex vivo, whole retinas were
isolated and 1-mm punches were loaded into wells of a 96-well
spheroid plate. Retinal punches were incubated in assay medium
[(DMEM, D5030, Sigma) supplemented with 25 mM glucose, 5 mM
HEPES and 2 mM glutamine, pH 7.4] with the presence of
0.1 pg ml1 msAPN or PBS (vehicle control) for 2 h before taking
measurements. For 661W cells in vitro, 4,000 cells per well were
placed in each well of a 96-well plate for 48 h and treated with
0.05–0.5 lM AdipoRon or DMSO (vehicle control) for 6 h before
taking measurements. To determine the amount of proton uncou-
pling (OCR independent of adenosine triphosphate production),
1.5 lM oligomycin, an adenosine triphosphate synthase inhibitor
was used for 661W cells. Due to the reported impact of oligomycin
on retinal OCR ex vivo (Kooragayala et al, 2015), we omitted this
step for retinal punches. To determine the maximal mitochondrial
respiration, the uncoupling agent carbonyl cyanide-4-trifluoro-
methoxy phenylhydrazone (FCCP, 0.5 lM for retinal punches; 1 lM
for 661W cells) was utilized. The non-mitochondrial respiration rate
was measured with the addition of rotentone (complex I inhibitor)
and antimycin A (complex III inhibitor) (2 lM for retinal punches;
1 lM for 661W cells).
Examination of mitochondrial morphology
661W cells were placed on a glass coverslip in a 6-well plate
(40,000 cells per well) at day (D) 0. At D1, the cells were treated
with 50 mM glucose with the presence of 0.5 nM AdipoRon or
DMSO (vehicle control) for 24 h. 50 mM mannitol was used as a
control for osmotic stress. At D2, the cells were incubated with pre-
warmed DMEM supplemented with 100 nM MitoTracker (#M7512,
Invitrogen) for 30 min at 37°C. After washing with PBS, the cells
were fixed with pre-warmed 4% paraformaldehyde for 15 min at
37°C and then incubated with 0.2% Triton X-100 PBS for 10 min at
room temperature. The cells were blocked with 1% bovine serum
albumin and stained with 1:40 F-actin (#A12379, Life Technologies)
for cell skeleton and DAPI for cell nuclei. The images were taken at
400× magnification on a Zeiss AxioObserver.Z1 microscope. The
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mitochondrial morphology was categorized as tubular, intermediate,
and fragmented (Eura et al, 2006; Zhao et al, 2009). The number of
cells was counted, and the percentage of cells within each mitochon-
dria category versus the total number of cells per imaging field was
calculated.
Real-time PCR
P10 retinas or 661W cells were lysed with QIAzol lysis reagent and
incubated on ice for 15 min; 20% chloroform was added and incu-
bated for 5 min at room temperature. RNA was extracted according
to the manufacturer’s instructions using a PureLink RNA Mini Kit
(#12183018A, Ambion). RNA was then reverse-transcribed using
iScriptTM cDNA synthesis kit (#1708891, Bio-Rad). qPCR were
performed for Apn: 50-GAAGCCGCTTATGTGTATCGC-30, 50-GAATG
GGTACATTGGGAACAGT-30; AdipoR1: 50-TCTTCGGGATGTTCTTCC
TGG-30, 50-TTTGGAAAAAGTCCGAGAGACC-30; AdipoR2: 50-GGAGT
GTTCGTGGGCTTAGG-30, 50-GCAGCTCCGGTGATATAGAGG-30; Cs:
50-CCAGTTCACCTCCCCCTCCTGG-30, 50-GGGCCTGTCCCTGGCGTA
GA-30; Fis1: 50-AGAGCACGCAATTTGAATATGCC-30, 50-ATAGTCCC
GCTGTTCCTCTTT-30; Hk1: 50-CAAGAAATTACCCGTGGGATTCA-30,
50-CAATGTTAGCGTCATAGTCCCC-30; Mff: 50-ATGCCAGTGTGATA
ATGCAAGT-30, 50-CTCGGCTCTCTTCGCTTTG-30; Mfn1: 50-ATGGC
AGAAACGGTATCTCCA-30, 50-CTCGGATGCTATTCGATCAAGTT-30;
Mfn2: 50-AGAACTGGACCCGGTTACCA-30, 50-CACTTCGCTGATAC
CCCTGA-30; Pdgfb: 50-TGCTACCTGCGTCTGGT-30, 50-GATGAGC
TTTCCAACTCGACTC-30. Quantitative analysis of gene expression
was generated using an Applied Biosystems 7300 Sequence Detec-
tion System with the SYBR Green Master mix kit, and gene expres-
sion was calculated relative to Cyclophilin A (retinas) or b-actin
(661W cells) using the DDCt method.
Western blot
40 lg protein lysate from 661W cells were used to detect the levels
of phosphor-AMPK (Ma et al, 2016) (p-AMPK, 1:1,000, #2535, Cell
Signaling) and AMPK (Almudena et al, 2016) (1:1,000, #2532, Cell
Signaling) overnight at 4°C. Signals were detected using 1:5,000
corresponding horseradish peroxidase-conjugated secondary anti-
bodies and enhanced chemiluminescence (ECL, Pierce).
Preparation of AAV2-RK-shPdgfb, AAV2-RK-shVegfa vector, and
AAV2 virus
ShRNA against mouse Pdgfb were designed as previously published
(Paddison et al, 2004). The template oligonucleotides contain miR-
30 microRNA, miR-30 loop and shRNA including the sense and the
antisense were synthesized (Invitrogen). The target sequence was
as follows: Pdgfb: 50-GGATCCCATTCCTGAGGAACT-30; ShVegfa: 50-
AACCTCACCAAAGCCAGCACAT-30; and Vegfa: 50-AACCTCAC-
CAAAGCCAGCACAT-30. DNA fragments were inserted into human
rhodopsin kinase (RK)-GFP-miR30 vector (Joyal et al, 2016). The
Pdgfb knockdown efficiency was tested in 661W cells. Recombinant
AAV2 vectors were then produced as before (Joyal et al, 2016).
AAV2 vector, rep/cap packaging plasmid, and adenoviral helper
plasmid were mixed with polyethylenimine in DMEM and trans-
fected into HEK293T cells (CRL-11268, ATCC). After 56 h, cells
were collected for virus purification using iodixanol. This protocol
was also used to prepare a control AAV2-shControl (GFP). 0.5 ll
virus (about 2 × 1012 gc ml1) was injected into the subretinal
space in WT mouse retina at P1. The samples were collected at P10
for the examination of retinal vascular development.
Statistical methods
Clinical data are presented as mean  SEM. For continuous vari-
ables, the t-test was used to test differences between groups. P-
values < 0.05 were considered significant. Statistical analyses were
performed using the program package IBM SPSS statistics 23 for
Microsoft Windows (IBM, Armonk, NY, USA). Animal data are
presented as mean  SEM. All data were used except for low-
quality images that were not sufficient for analysis. The number
per group (n) was shown in figure legends. For drug treatments,
the mice were randomly assigned to treatment and vehicle control
in the same litter. For in vitro study, the experiment was repeated
at least three independent times. The experimenters were blinded
to the treatment conditions. Sample size was computed by
G*Power3 (Faul et al, 2007) to allow 80% power (set b to 0.2)
and set a to 0.05. D’Agostino & Pearson omnibus normality test
was used to confirm normal distribution. F-test was used to
compare the variance. Two-tailed unpaired t-test or ANOVA with
Bonferroni’s multiple comparison test was used for comparison of
results as specified (Prism v5.0; GraphPad Software, Inc., San
Diego, CA, USA). Data with non-Gaussian distribution were
analyzed by Kruskal–Wallis test followed by Dunn’s multiple
comparisons test (nonparametric, three groups) or Mann–Whitney
The paper explained
Problem
Retinopathy of prematurity is a common complication in premature
infants and a leading cause of blindness in children. The factors and
neural cells determining normal vascular growth are not well defined
even though delayed vascular growth (phase I) drives vision-threa-
tening neovessel growth (phase II). Hyperglycemia and low adipo-
nectin (APN, a key metabolic regulator) levels correlate with the
progression of phase II ROP. We examined whether these effects are
driven primarily by dysregulated photoreceptor metabolism which
delays normal retinal vascularization at phase I ROP.
Results
The present study describes that in premature infants, low APN levels
correlate with hyperglycemia and delayed retinal vascular formation.
Experimentally in a newly established neonatal mouse model of
hyperglycemic ROP, hyperglycemia causes photoreceptor dysfunction
and delays neurovascular maturation. Activation of the APN pathway
normalizes vascular growth and restored retinal function. APN defi-
ciency decreases retinal metabolism particularly in photoreceptors
and decreases photoreceptor-derived growth factors for vascular
development.
Impact
Our work reveals the impact of hyperglycemia and APN on normal
retinal vessel growth in phase I ROP and explores a new therapeutic
intervention (stimulation of the APN pathway) at early stages to
improve hyperglycemia-associated retinal neurovascular disorders like
retinopathy of prematurity in preterm infants with implications for
diabetic retinopathy in adults.
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test (nonparametric, two groups). Statistically significant difference
was set at P ≤ 0.05. The results of statistical analysis are shown in
Table EV2.
Study approval
The clinical study was approved by the Regional Ethical Review Board
in Lund, Sweden. Inclusion criteria were a gestational age < 31 weeks
at birth, absence of major congenital anomalies, and written informed
parental consent from both parents. All pregnancies were dated by
ultrasound at 17–18 gestational weeks. Fifty-one infants completed
the study until term age and longitudinal plasma glucose and adipo-
nectin concentrations were analyzed in all infants. Written informed
consent was obtained from parents for all study infants. The prospec-
tive longitudinal cohort study was conducted between January 2005
and May 2007. Previous data reported on this cohort include the rela-
tionship between circulatory insulin-like growth factor concentrations
and postnatal growth, brain volumes, and outcome (Hellstrom et al,
2003; Hansen-Pupp et al, 2011, 2013; Fu et al, 2015). All animal stud-
ies adhered to the Association for Research in Vision and Ophthalmol-
ogy Statement for the Use of Animals in Ophthalmic and Vision
Research and were approved by the Institutional Animal Care and Use
Committee at Boston Children’s Hospital.
Data availability
The raw data of retinal proteomics was published in BioStudies
(https://zenodo.org/, accession number 1054112).
Expanded View for this article is available online.
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